نتایج جستجو برای: ras mutations

تعداد نتایج: 198454  

Journal: :Molecular and cellular biology 1994
L A Quilliam K Kato K M Rabun M M Hisaka S Y Huff S Campbell-Burk C J Der

The Ras(17N) dominant negative antagonizes endogenous Ras function by forming stable, inactive complexes with Ras guanine nucleotide exchange factors (GEFs; e.g., SOS1). We have used the growth-inhibitory phenotype of Ras(17N) to characterize two aspects of Ras interaction with GEFs. First, we used a nonprenylated version of Ras(17N), designated Ras(17N/186S), which no longer associates with th...

Journal: :The European respiratory journal 1999
V A Somers A M van Henten G P ten Velde J W Arends F B Thunnissen

The purpose of this study was to examine the additional diagnostic value of K-ras point mutations in the clinical diagnosis of peripheral lung tumours. To this end, bronchial wash fluids obtained during bronchoscopy from patients suspected of having lung cancer were studied. Only those patients were investigated for whom the cytological diagnosis was not conclusive for malignancy. As a control ...

Journal: :BMC Gastroenterology 2008
Charles E Patek Mark J Arends Lorraine Rose Feijun Luo Marion Walker Paul S Devenney Rachel L Berry Nicola J Lawrence Rachel A Ridgway Owen J Sansom Martin L Hooper

BACKGROUND Alterations in gene splicing occur in human sporadic colorectal cancer (CRC) and may contribute to tumour progression. The K-ras proto-oncogene encodes two splice variants, K-ras 4A and 4B, and K-ras activating mutations which jointly affect both isoforms are prevalent in CRC. Past studies have established that splicing of both the K-ras oncogene and proto-oncogene is altered in CRC ...

Journal: :Blood 2009
Briony A Cutts Anna-Karin M Sjogren Karin M E Andersson Annika M Wahlstrom Christin Karlsson Birgitta Swolin Martin O Bergo

Hyperactive RAS signaling is caused by mutations in RAS genes or a deficiency of the neurofibromatosis gene (NF1) and is common in myeloid malignancies. In mice, expression of oncogenic K-RAS or inactivation of Nf1 in hematopoietic cells results in myeloproliferative disorders (MPDs) that do not progress to acute myeloid leukemia (AML). Because NF1 is a RAS-GTPase-activating protein it has been...

2017
J Vidal L Muinelo A Dalmases F Jones D Edelstein M Iglesias M Orrillo A Abalo C Rodríguez E Brozos Y Vidal S Candamio F Vázquez J Ruiz M Guix L Visa V Sikri J Albanell B Bellosillo R López C Montagut

Background RAS assessment is mandatory for therapy decision in metastatic colorectal cancer (mCRC) patients. This determination is based on tumor tissue, however, genotyping of circulating tumor (ct)DNA offers clear advantages as a minimally invasive method that represents tumor heterogeneity. Our study aims to evaluate the use of ctDNA as an alternative for determining baseline RAS status and ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2003
Janivette Alsina David H Gorsk F Joseph Germino Weichung Shih Shou-En Lu Zhi-Gang Zhang Jin-Ming Yang William N Hait James S Goydos

PURPOSE Recent studies suggest that activating point mutations in B-RAF may commonly occur in melanoma. We devised a method to detect point mutations in heterogeneous tissues containing both wild-type and mutant B-RAF and N-RAS genes by using site-directed mutagenesis to introduce new restrictions sites in the cDNA sequence when the specific point mutations are present. We used this technique t...

Journal: :Journal of Carcinogenesis 2005
Roland Houben Jürgen C Becker Ulf R Rapp

BACKGROUND Activation of Ras or Raf contributes to tumorigenesis of melanoma. However, constitutive Raf activation is also a characteristic of the majority of benign melanocytic nevi and high intensity signaling of either Ras or Raf was found to induce growth inhibition and senescence rather than transformation. Since the chromosome 3p kinase (3pK)) is a target of the Ras/Raf/Mek/Erk signaling ...

2017
Sezen Vatansever Zeynep H. Gümüş Burak Erman

K-Ras is the most frequently mutated protein in human tumors. Activating K-Ras mutations drive cancer initiation, progression and drug resistance, directly leading to nearly a million deaths per year. To understand the mechanisms by which mutations alter K-Ras function, we need to understand their effects on protein dynamics. However, despite decades of research, how oncogenic mutations in K-Ra...

2018
Kasumi Dendo Takashi Yugawa Tomomi Nakahara Shin-ichi Ohno Naoki Goshima Hirofumi Arakawa Tohru Kiyono

Oncogenic mutations of RAS genes, found in about 30% of human cancers, are considered to play important roles in cancer development. However, oncogenic RAS can also induce senescence in mouse and human normal fibroblasts. In some cell lines, oncogenic RAS has been reported to induce non-apoptotic programed cell death (PCD). Here, we investigated effects of oncogenic RAS expression in several ty...

Journal: :Carcinogenesis 2002
Juan Alguacil Miquel Porta Núria Malats Timo Kauppinen Manolis Kogevinas Fernando G Benavides Timo Partanen Alfredo Carrato

Occupational exposure to hydrocarbon solvents has been found to be associated with an increased risk of exocrine pancreatic cancer (EPC), the human tumor with the highest prevalence of K-ras mutations. Ras genes are critical DNA targets for chemical carcinogens. We analysed the relationship between past occupational exposure to hydrocarbon solvents and mutations in codon 12 of the K-ras gene in...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید